Pancreatic Cancer Research

ResearcherTUM KlinikumNo recent work listed

Ayse Ceren Mutgan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4981-3646; OpenAlex author ID A5045057532. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer. First author DOI 10.3390/cancers13020249↗
  2. Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer. Co-author DOI 10.1186/s12943-018-0806-0↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Helmut Frieß · 2 shared papers, 2018–2021 · strength 0.22
  2. İhsan Ekin Demir · 2 shared papers, 2018–2021 · strength 0.22
  3. Guralp Onur Ceyhan · 2 shared papers, 2018–2021 · strength 0.22
  4. Lei Ren · 1 shared paper, 2021 · strength 0.12
  5. Rüdiger Göß · 1 shared paper, 2021 · strength 0.12
  6. Pavel Stupakov · 1 shared paper, 2021 · strength 0.12
  7. Okan Safak · 1 shared paper, 2021 · strength 0.12
  8. H. Erdinc Besikcioglu · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.